Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Change in Inventory (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Change in Inventory for 13 consecutive years, with -$112000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 66.77% to -$112000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $275000.0, a 207.0% increase, with the full-year FY2025 number at $275000.0, up 207.0% from a year prior.
  • Change in Inventory was -$112000.0 for Q4 2025 at Ekso Bionics Holdings, up from -$494000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $659000.0 in Q2 2022 to a low of -$494000.0 in Q3 2025.
  • A 5-year average of $96900.0 and a median of $53000.0 in 2021 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: soared 816.3% in 2022, then plummeted 795.77% in 2025.
  • Ekso Bionics Holdings' Change in Inventory stood at $581000.0 in 2021, then crashed by 113.25% to -$77000.0 in 2022, then plummeted by 411.69% to -$394000.0 in 2023, then increased by 14.47% to -$337000.0 in 2024, then skyrocketed by 66.77% to -$112000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Change in Inventory are -$112000.0 (Q4 2025), -$494000.0 (Q3 2025), and $502000.0 (Q2 2025).